MASTRANGELO, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 200
EU - Europa 135
AS - Asia 34
AF - Africa 2
SA - Sud America 1
Totale 372
Nazione #
US - Stati Uniti d'America 198
SE - Svezia 76
IT - Italia 36
CN - Cina 22
FI - Finlandia 11
DE - Germania 7
IN - India 6
PH - Filippine 4
MD - Moldavia 3
CA - Canada 2
TN - Tunisia 2
BR - Brasile 1
IR - Iran 1
MK - Macedonia 1
NL - Olanda 1
SG - Singapore 1
Totale 372
Città #
Ashburn 48
Shanghai 20
New York 18
Lawrence 16
Princeton 16
Boardman 14
Washington 11
Helsinki 10
Seattle 5
Vittoria 5
Pune 4
Quezon City 4
Angera 3
Borås 3
Chisinau 3
Milan 3
Hyderabad 2
Padova 2
Segrate 2
Torre Del Greco 2
Verona 2
Amsterdam 1
Falkenstein 1
Huskvarna 1
Lainate 1
Lappeenranta 1
Mahestan 1
Montréal 1
Paliano 1
Pavia 1
Pisa 1
Reston 1
Rome 1
San Sperate 1
Santa Clara 1
Skopje 1
Totale 208
Nome #
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 43
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 31
Candidemia in COVID-19 patients: incidence and characteristics in a prospective cohort compared to historical non-COVID-19 controls 28
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 26
Brief Report: Association Between Low HIV-1 DNA and Western Blot Reactivity to HIV-1 Pol in Chronically Infected Individuals 23
Coronavirus Disease 2019 in Recipient of Allogeneic Hematopoietic Stem Cell Transplantation: Life-threating Features Within the Early Post-engraftment Phase 23
Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 (Scientific Reports, (2020), 10, 1, (21291), 10.1038/s41598-020-78039-1) 23
The Elephant in the Room: Secondary Infections and Antimicrobial Use in Patients With COVID-19 23
Dynamics of HIV-1 POL antibodies after ART in chronic HIV-1 infection 20
Anti-HIV antibodies are representative of the latent reservoir but do not correlate with viral control in people with long-lasting virological suppression undergoing analytical treatment interruption (APACHE study) 20
Serum IgG1 and IgG4 could contribute to partial control of viral rebound in chronically HIV-1-infected patients 20
VIRO-immunological outcomes after 13-valent pneumococcal vaccination in HIV-1-infected individuals on stable virological suppression 18
Invasive fungal infections in patients with COVID-19: a review on pathogenesis, epidemiology, clinical features, treatment, and outcomes 18
Retrospective study on the outcome of two-drug regimens based on dolutegravir plus one reverse transcriptase inhibitor in virologically-suppressed HIV-infected patients 17
Western blot in treated people with HIV-1 chronic infection: frequency of negative HIV-1 pol genes 17
HIV-DNA undetectability during chronic HIV infection: Frequency and predictive factors 16
Switching from a Non-Protease inhibitor-Based Regimen To the Fixed Dose Combination of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Clinical Practice 15
High-dose anakinra in addition to standard of care including corticosteroids in patients with severe COVID-19 treated with non-invasive ventilation 14
Rhodococcus defluvii pneumonia: First reported case in humans 14
Totale 409
Categoria #
all - tutte 4.120
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.120


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202119 0 0 0 4 0 10 0 3 1 0 1 0
2021/202243 0 0 0 6 0 6 4 6 4 3 2 12
2022/2023134 40 30 10 2 6 13 8 15 5 0 1 4
2023/2024213 8 19 48 15 26 52 2 24 0 1 4 14
Totale 409